Slamming Cancer: A Conversation with Steve Potts, CEO of SLAM BioTherapeutics

from The Commons · host Wexford Science & Technology

Commons host, Thomas Osha, catches up with serial entrepreneur, Steve Potts, to discuss his latest venture, SLAM BioTherapeutics. Slam Bio is developing a platform of first-in-class monoclonal antibody therapies and antibody-drug conjugates (ADCs) targeting cancer, beginning with blood cancers. The conversation took place at the BIO International Conference 2024 in San Diego June 4-6, 2024.https://slambio.com/

Episode metadata supplied by the publisher feed · Published Jun 18, 2024

Embed this episode

Attribution link and audio player

Ready to play

Slamming Cancer: A Conversation with Steve Potts, CEO of SLAM BioTherapeutics

0:00 10:08

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Commons?

This episode is 10 minutes long.

When was this The Commons episode published?

This episode was published on June 18, 2024.

Can I download this The Commons episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!